Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis

• Wei Fan,
• Yifei Ma,
• Nianqi Liu,
• Youlong Wang,
• Jiling Zeng,
• Ying-Ying Hu,
• Wu Hao,
• Huazheng Shi,
• Pengfei Zhu,
• Xinjia Wang

Affiliations

Wei Fan

1Department of Clinical Laboratory & Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China

Yifei Ma

Department of Orthopedics & Spine Surgery, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, People`s Republic of China

Nianqi Liu

Lab for Post-traumatic Stress Disorder, Faculty of Psychology and Mental Health, Naval Medical University, Shanghai, People`s Republic of China

Youlong Wang

Department of General Surgery, Hainan Hospital of PLA General Hospital, Sanya City, Hainan Province, People`s Republic of China

Jiling Zeng

Department of Nuclear Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People`s Republic of China

Ying-Ying Hu

Department of Nuclear Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People`s Republic of China

Wu Hao

Department of Breast Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People`s Republic of China

Huazheng Shi

Department of Nuclear Medicine, Shanghai Universal Medical Imaging Center, Shanghai, People`s Republic of China

Pengfei Zhu

Department of Clinical Laboratory, Zhengzhou University First Affiliated Hospital, Zhengzhou, Henan, People`s Republic of China

Xinjia Wang

Department of Orthopedics & Spine Surgery, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, People`s Republic of China